VAX-D® Treatment provides relief for patients suffering from the common causes of low back pain and radicular pain. These conditions include discs that are herniated or degenerated, as well as posterior facet syndromes.
Many people with these diagnoses experience relief of their pain. Posterior facet syndromes respond to distraction achieved through VAX-D® Treatment.
A VAX-D® clinic practitioner will determine your course of treatment and whether or not you are a candidate.
Patients with certain conditions such as tumors, fractures, gross osteoporosis or pars defects-grade II are not candidates for this treatment.
VAX-D® is effective and safe
AX-D is a non-invasive treatment for chronic back pain and neck pain from disc and facet joint disease. VAX-D is an effective and safe procedure without any of the risks associated with surgery, injections, or anesthesia. Time off work or in recovery is minimal, and resolution of symptoms can be long lasting. A new study published in 2008 showed that patients had significantly improved pain and disability scores at end of treatment, at 30 days and at 180 days post-discharge.
Low back pain has become one of the most significant medical problems in today’s world. The statistics on the magnitude of the problem are overwhelming, and the number of chronic back cases continues to grow each day. In fact, low back pain that is related to work is the most common complaint presented to primary care physicians and workers compensation.
Often, the symptoms of back pain are treated with a drugs, heat and cold, bed-rest, chiropractic/manipulation, physical therapy, exercises, acupuncture, TENS, epidural injections, prolotherapy, IDET (Intradiscal Electrothermal Therapy or heat cauterization with an electrothermal catheter) and the various types of surgery. Many of these are simply aimed at providing a temporary reduction of symptoms without altering the underlying disease process. Physicians are faced with the fact that there is no universally accepted standard for the care of such patients.
Surgery may disrupt the natural biomechanical functions essential to preserve pain-free spinal mobility. The majority of back pain patients are not ideal surgical candidates; and surgery in the poorly selected patient can le ad to ‘failed back syndrome’. Before resorting to a surgical approach, it makes sense to try a conservative procedure. If a patient doesn’t recover in the first two months, the initial benign problem may become a chronic situation. This is why it is so important to begin treatment early.
VAX-D can relieve the pain associated with herniated discs, degenerative disc disease, posterior facet syndrome and radicular (nerve root) pain. Patients can avoid the merry-go-round of drugs and non-specific treatments.
VAX-D clinics have been now been successfully operating for over 15 years in the US, as well as in Canada, Mexico, United Kingdom, Spain, Italy, Columbia, Guatemala, Thailand and Australia. More than 3000 patients a day now receive VAX-D therapy in the US.
Results from all of the independent sources (hospitals, private clinics, clinical studies) show levels of success in the range of 7+ out of 10 people.
VAX-D therapy has been used by the best professional sports figures including those in the NBA, NFL, NHL, Olympic athletes and more.
VAX-D is the only medical device that delivers treatment with the patented logarithmic decompression curve.
The results with VAX-D are real, and based upon research published in peer-reviewed medical journals.
Today there is an entire industry of ‘spinal decompression’ devices, all based upon developments pioneered by VAX-D. Prior to the research on negative disc pressures with VAX-D (in 1994), non-surgical decompression did not exist. VAX-D Medical Technologies patented the process know as ‘vertebral decompression’.
This ‘spinal decompression’ industry is so full of mis-information, unsubstantiated claims and marketing hype, that it is difficult to find credibility in any of the devices. Many use research done on VAX-D equipment – as though it applies to their device. Manufacturers masquerade articles about ‘decompression’ as clinical research studies. It is disconcerting that the industry has grown so large, when a search of the medical literature reveals there are no studies published in peer-reviewed medical journals on other devices.
Many spinal decompression device manufacturers claim that their device will lower the intradiscal pressure. To this day, VAX-D is the only device shown in clinical research to decompress the discs to negative levels (Ramos G., Martin W. Journal of Neurosurgery).
